Fractional shares
Get dividend payments
Formed in 2005 as "Big Hit Entertainment" (and rebranded in 2021), Hybe is the record label behind popular K-pop boy band BTS.
The company floated in October 2020 on South Korea’s KOSPI. Demand for Hybe’s stock was high among retail and institutional investors alike. In fact, some 1,420 institutional investors wanted pre-subscription access to Big Hit’s IPO, amounting to 1,117 times the subscription amount allotted to institutional investors. The stock opened at 270,000 won (USD$235) and saw a surge in price on its first day. This was followed by a second-day drop, but nonetheless, it was enough to make the seven members of BTS multimillionaires.
Since going public, Hybe has been acquiring other labels and in 2023 launched a Latin music division.
Unfortunately, shares aren't available on UK exchanges, and so far we haven't heard anything suggesting the company is planning a US IPO. You can still buy Hybe stocks from the UK, but you'll need an international brokerage account. That might sound fiddly, but in fact most mainstream trading apps now support investing in foreign stocks.
To make comparing even easier we came up with the Finder Score. Costs, features, ease and range of investments across 30+ platforms are all weighted and scaled to produce a score out of 10. The higher the score the better the platform – simple.
Read the full methodologyAll investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Hybe), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Hybe is a major part of the KO, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
January 10, 2025: K-Pop star J-Hope of BTS announced a solo world tour, and markets responded positively – with the Hybe stock price surging 7%. 2025 is already set to be a big year for both BTS and its label, with the boy band's big comback scheduled for June, and the potential of new music from BTS and J-Hope as a solo artist.
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
View Hybe's price performance, share price volatility, historical data and technicals.
Historical closes compared with the last close of ₩214.00
1 week (2024-12-31) | |
---|---|
1 month (2024-12-12) | -99.90% |
3 months (2024-10-13) | -99.88% |
6 months (2024-07-11) | -99.89% |
1 year (2024-01-11) | -99.91% |
2 years (2023-01-12) | -99.88% |
3 years (2022-01-13) | -99.92% |
5 years (2020-01-07) |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Ever wondered how to buy shares in Canopy Growth? We explain how and compare a range of providers that can give you access to many brands, including Canopy Growth.
Ever wondered how to buy shares in Green Thumb Industries? We explain how and compare a range of providers that can give you access to many brands, including Green Thumb Industries.
Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.
Ever wondered how to buy shares in Genesis Healthcare? We explain how and compare a range of providers that can give you access to many brands, including Genesis Healthcare.
Ever wondered how to buy shares in Allergy Therapeutics? We explain how and compare a range of providers that can give you access to many brands, including Allergy Therapeutics.
Ever wondered how to buy shares in 4D pharma? We explain how and compare a range of providers that can give you access to many brands, including 4D pharma.
Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.
Thinking about buying shares in Evgen Pharma? We explain how to do it and compare a range of providers who will give you access to global markets.
Ever wondered how to buy shares in Intuitive Surgical? We explain how and compare a range of providers that can give you access to many brands, including Intuitive Surgical.
Ever wondered how to buy shares in Stryker? We explain how and compare a range of providers that can give you access to many brands, including Stryker.